🎯 Exciting advances in the treatment of rare chordomas as we continue to celebrate National Cancer Research Month! A new study from Mayo Clinic shows that #ProtonTherapy significantly reduces the chance of tumor recurrence compared to traditional photon radiotherapy post-surgery. Researchers found that patients undergoing proton therapy have a notably lower recurrence rate—40% vs. 88% in photon therapy.
🔬 Utilizing tree-based machine learning, this study predicts long-term outcomes with impressive accuracy, highlighting the effectiveness of proton therapy in managing these challenging tumors. Dive deeper into the findings and discover how precision in treatment can make a world of difference for positive patient outcomes. #Chordoma #NCRM #MedicalInnovation
🔗 Read more at the American Association of Neurological Surgeons (AANS) Journal of Neurosurgery Publishing Group:
https://lnkd.in/dsDiVCcR
Abdul Karim Ghaith M.D.
Ryan Nguyen, MD, MEng
Victor Gabriel E.
Alaa Montaser, MBBCh
Gaetano De Biase, MD
Krishnan Ravindran, MD
Carlos Pérez-Vega
Seung Jin Lee, MD
Asmina Dominari, MD
Umberto Battistin
Paola Suárez Meade, MD
Charbel Moussalem
Naresh P. Patel, MD FAANS
Maziyar Kalani, MD
Michelle Clarke
Peter S. Rose, MD
Mohamad Bydon
Kingsley Abode-Iyamah MD FAANS
Oluwaseun Akinduro
American Association for Cancer Research
Physician and Clinical Researcher
1wMany congratulations ma'am